Vitamina D y Salud ArticularREAD MORE
Osteoarthritis and cardiovascular risk: What do we need to know? Osteoarthritis: Key concepts Osteoarthritis (OA) is a chronic disease that affects the cartilage, the subchondral bone, the synovial membrane and the soft tissues of the joint. Some of the symptoms are pain, loss of mobility, muscle atrophy… which are combined with the psychological wear and […]READ MORE
SEMERGEN joins the OAFI Foundation in the development of the “OAFI With You” project, aimed at assisting religious patients with joint health problems. The Spanish Society of Primary Care Physicians (SEMERGEN) and the Osteoarthritis Foundation International (OAFI) have signed a collaboration agreement to promote the development of the “OAFI With You” project, focused on providing […]READ MORE
OAFI presents White Paper on Aging and Osteoarthritis In 2050, 31.4% of the Spanish population will be over 65 years old and 11.6% will be over 80. Last Thursday, June 29, OAFI officially presented the White Paper on Aging and Osteoarthritis: Problems, Challenges and Solutions, prepared jointly with Dr. Julio Sánchez Fierro, lawyer and doctor […]READ MORE
Always working towards quality of life At the OAFI Foundation we work to improve the quality of life of patients with Osteoarthritis. To achieve this goal, there are different areas of work in which the OAFI Foundation dedicates its efforts; one of them is Research and Development, where we coordinate, lead and take part in […]READ MORE
OAFI FOUNDATION HOSTED THE LAUNCHING OF THE ORGANIZATION EUROPEAN COOPERATION IN SCIENCE AND TECHNOLOGY On January 23rd and 24th, in Barcelona, the OAFI Foundation hosted the launching of the European Cooperation in Science and Technology, (COST), a funding organization for research and innovation networks at European level in the field of osteoarthritis. At these meetings, […]READ MORE
The agreement, signed this Tuesday by Dr. Josep Vergés, Founder and President of OAFI, and Prof. F. Javier de la Mata, Vice-Rector for Research and Transfer of the University of Alcalá, will focus on pharmacological research into osteoarthritis and the locomotor system. The Osteoarthritis Foundation International (OAFI) and the University of Alcalá (UAH), have signed […]READ MORE
Last November, SEIOMM (Spanish Society for Bone and Mineral Metabolism Research) and the Osteoarthritis Foundation International (OAFI) signed a collaboration agreement between both parties, in which they undertook to work together to tackle osteoarthritis and osteoporosis. Osteoarthritis, a chronic disease erroneously associated with old age, already affects more than 7 million people in Spain, with […]READ MORE
The TRIANKLE consortium –made up of 12 European organisations (one of them OAFI Foundation)–, will develop 3D bioprinted personalised scaffolds for tissue regeneration of ankle joints. The main objective of this project is to reduce the time of recovery down to 50% and increase the functionality ratios up to 10-15%. The TRIANKLE consortium –made up […]READ MORE
The journal of the Spanish Society of Rheumatology (SER), Clinical Rheumatology, has just published part of the results of a study promoted by the International Foundation for Patients with Osteoarthritis, OAFI, which clarifies the use of SYSADOAs in the treatment of Osteoarthritis in Primary Care: "Expert Paper on the Appropriate Use of SYSADOAs in Controversial Clinical Situations."READ MORE
BECOME A PARTNER
Help us improve the quality of life of osteoarthritis patients by becoming a partner.
BECOME A VOLUNTEER
The patient is the reason for being OAFI, become a volunteer and help us improve their quality of life.
MAKE A DONATION
Your help is very important to us, with it we can finance our founding work.